BlackRock Fund Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History

BlackRock Fund Advisors’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$11.3M	Buy	1,580,116 +190,713	+14%	+$1.54M	﹤0.01%	2498
2016 Q3	$13M	Buy	1,389,403 +80,724	+6%	+$670K	﹤0.01%	2320
2016 Q2	$8.27M	Buy	1,308,679 +98,007	+8%	+$630K	﹤0.01%	2514
2016 Q1	$6.68M	Buy	1,210,672 +13,402	+1%	+$50.4K	﹤0.01%	2587
2015 Q4	$6.68M	Sell	1,197,270 -83,354	-7%	-$551K	﹤0.01%	2681
2015 Q3	$10.8M	Buy	1,280,624 +43,185	+3%	+$731K	﹤0.01%	2343
2015 Q2	$18.7M	Sell	1,237,439 -7,239	-0.6%	-$105K	﹤0.01%	2150
2015 Q1	$19.9M	Buy	1,244,678 +39,056	+3%	+$695K	﹤0.01%	2073
2014 Q4	$21.5M	Buy	1,205,622 +529,960	+78%	+$6.6M	0.01%	2029
2014 Q3	$6.78M	Buy	675,662 +73,108	+12%	+$886K	﹤0.01%	2573
2014 Q2	$9.41M	Buy	602,554 +376,739	+167%	+$5.34M	﹤0.01%	2458
2014 Q1	$4.19M	Buy	225,815 +44,899	+25%	+$900K	﹤0.01%	2927
2013 Q4	$3.46M	Sell	180,916 -3,706	-2%	-$75.2K	﹤0.01%	3011
2013 Q3	$3.02M	Buy	+184,622	New	+$1.94M	﹤0.01%	3044

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Fund Advisors's PETX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Aratana Therapeutics, Inc. (PETX) stake by 14% in Q4 2016, buying an estimated $1.54M and bringing the position to 1,580,116 shares worth $11.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2498.

BlackRock Fund Advisors first reported a position in PETX in Q3 2013 and has held it in 14 quarters since. The position peaked at $21.5M in Q4 2014. 107 funds tracked by Wall St. Rank hold PETX as of Q4 2016.

BlackRock Fund Advisors held 1,580,116 shares of Aratana Therapeutics, Inc. worth $11.3M as of Q4 2016.
BlackRock Fund Advisors bought 190,713 Aratana Therapeutics, Inc. shares in Q4 2016, an estimated $1.54M.
Aratana Therapeutics, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2498 holding.
BlackRock Fund Advisors first reported a position in Aratana Therapeutics, Inc. in Q3 2013 and has held it in 14 quarters since.
BlackRock Fund Advisors's Aratana Therapeutics, Inc. position peaked at $21.5M in Q4 2014.
107 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.